Skip to main content
See every side of every news story
Published • loading... • Updated

Arbutus Biopharma Corporation (NASDAQ:ABUS) Stock Short Interest Rises 84.2%

Summary by MarketBeat
Arbutus Biopharma Corporation (NASDAQ:ABUS - Get Free Report) was the recipient of a large increase in short interest in September. As of September 30th, there was short interest totaling 34,053,358 shares, an increase of 84.2% from the September 15th total of 18,484,910 shares. Currently, 21.5% of the company's stock are short sold. Based on an average trading volume of 9,652,199 shares, the short-interest ratio is presently 3.5 days.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Thursday, October 15, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal